Similarly, knocking down eIF5B decreased the levels of programmed death-ligand 1 (PD-L1) in heme starved non-small cell lung cancer (NSLC) and lewis lung carcinoma (LLC) cells (Suresh et al., 2020). Here, EIF5B is linked to non-small cell lung carcinoma.